English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 8, 2026

Researchers identify flaw in AI models used for sepsis treatment recommendations
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

Researchers identify immune pathway as potential target for Huntington disease therapy
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

Online tool shows high satisfaction among cancer trial participants, study finds
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

RevMed and Tango report 92% response rate in pancreatic cancer drug combination trial
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA introduces new pathways for rare disease drug development, raising questions among experts
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

Roche announces up to $3 billion deal with Nurix for blood cancer drug development
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

Survey finds many Americans unaware of diet's impact on cholesterol levels
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

Researchers study impact of paternal alcohol use on child development and health

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes